Monopar Therapeutics (MNPR) Gains from Investment Securities (2018 - 2019)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Monopar Therapeutics' Gains from Investment Securities history spans 2 years, with the latest figure at $1.1 million for Q4 2019.

• For Q4 2019, Gains from Investment Securities rose 1754.41% year-over-year to $1.1 million; the TTM value through Dec 2019 reached $1.1 million, changed N/A, while the annual FY2023 figure was $46969.0, 38.71% down from the prior year.
• Gains from Investment Securities for Q4 2019 was $1.1 million at Monopar Therapeutics, up from -$65731.0 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $1.1 million in Q4 2019 and bottomed at -$65731.0 in Q4 2018.

Peer Comparison